Literature DB >> 1939199

The murine adenosine deaminase promoter requires an atypical TATA box which binds transcription factor IID and transcriptional activity is stimulated by multiple upstream Sp1 binding sites.

J W Innis1, D J Moore, S F Kash, V Ramamurthy, M Sawadogo, R E Kellems.   

Abstract

We have explored the template and factor requirements for in vitro transcription of the GC-rich promoter of the murine adenosine deaminase gene. The core promoter consists of an A-rich sequence (TAAAAAA) 27 base pairs upstream of the initiation site which binds transcription factor IID (TFIID) and a high affinity Sp1 binding site located 27 base pairs further upstream. Multiple upstream elements increased core promoter activity 20-fold and correspond to protected regions in DNase I footprinting assays with purified Sp1 protein. Internal deletion of the TA6 element alone eliminated transcription in spite of the presence of all other promoter elements including four Sp1 binding sites. Recombinant human TFIID supported weak basal transcription in heat-treated nuclear extracts whereas a partially purified TFIID fraction from HeLa cells reconstituted a maximal level of transcription. Inclusion of 12 base pairs immediately adjacent to the proximal Sp1 site resulted in a 5-fold boost in transcriptional activity and corresponds to a second Sp1 binding site. These results serve as a basis for further exploration of the factors involved in the developmental and selective high level tissue expression of the murine adenosine deaminase gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  In vitro activity of the baculovirus late expression factor LEF-5.

Authors:  Linda A Guarino; Wen Dong; Jianping Jin
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Identification of preferred hTBP DNA binding sites by the combinatorial method REPSA.

Authors:  P Hardenbol; J C Wang; M W Van Dyke
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

3.  An inverted TATA box directs downstream transcription of the bone sialoprotein gene.

Authors:  J J Li; R H Kim; J Sodek
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

4.  Oxidative stress and superoxide dismutase in development, aging and gene regulation.

Authors:  R G Allen
Journal:  Age (Omaha)       Date:  1998-04

5.  Functional analysis of a stable transcription arrest site in the first intron of the murine adenosine deaminase gene.

Authors:  S F Kash; J W Innis; A U Jackson; R E Kellems
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

6.  Sp1 is essential for both enhancer-mediated and basal activation of the TATA-less human adenosine deaminase promoter.

Authors:  M R Dusing; D A Wiginton
Journal:  Nucleic Acids Res       Date:  1994-02-25       Impact factor: 16.971

7.  Characterization of the survival motor neuron (SMN) promoter provides evidence for complex combinatorial regulation in undifferentiated and differentiated P19 cells.

Authors:  Raphaël Rouget; François Vigneault; Circé Codio; Camille Rochette; Isabelle Paradis; Régen Drouin; Louise R Simard
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

8.  Disruption of the adenosine deaminase (ADA) gene using a dicistronic promoterless construct: production of an ADA-deficient homozygote ES cell line.

Authors:  S Vaulont; S Daines; M Evans
Journal:  Transgenic Res       Date:  1995-07       Impact factor: 2.788

9.  The murine G+C-rich promoter binding protein mGPBP is required for promoter-specific transcription.

Authors:  Li-Chung Hsu; Shu Liu; Ferishteh Abedinpour; Robert D Beech; Jill M Lahti; Vincent J Kidd; Jeffrey A Greenspan; Cho-Yau Yeung
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  Control of transcription arrest in intron 1 of the murine adenosine deaminase gene.

Authors:  S F Kash; R E Kellems
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.